REPORT ID 3116

Asia-Pacific Helminthic Infestations Therapeutics Market Report 2017

Publish Date
12-Dec-17
Pages
102
Format
Electronic (PDF)

In this report, the Asia-Pacific Helminthic Infestations Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Helminthic Infestations Therapeutics for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Helminthic Infestations Therapeutics market competition by top manufacturers/players, with Helminthic Infestations Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Neural Analytics, Inc.
    M3 Biotechnology, Inc.
    Cerevance
    Mitochon Pharmaceuticals, Inc.
    Peptilogics
    Farmoquimica S/A
    biOasis Technologies, Inc.
    HCA Healthcare, Inc.
    Alzeca Biosciences, Inc.
    Johnson & Johnson

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Benzimidazole
    Pyrantel
    Piperazine Citrate
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Enterobius vermicularis
    Taenia saginata
    Ascaris lumbricoides
    Trichuris trichiura
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Helminthic Infestations Therapeutics Market Report 2017
1 Helminthic Infestations Therapeutics Overview
    1.1 Product Overview and Scope of Helminthic Infestations Therapeutics
    1.2 Classification of Helminthic Infestations Therapeutics by Product Category
        1.2.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Helminthic Infestations Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Benzimidazole
        1.2.4 Pyrantel
        1.2.5 Piperazine Citrate
        1.2.6 Others
    1.3 Asia-Pacific Helminthic Infestations Therapeutics Market by Application/End Users
        1.3.1 Asia-Pacific Helminthic Infestations Therapeutics Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Enterobius vermicularis
        1.3.3 Taenia saginata
        1.3.4 Ascaris lumbricoides
        1.3.5 Trichuris trichiura
        1.3.6 Others
    1.4 Asia-Pacific Helminthic Infestations Therapeutics Market by Region
        1.4.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Helminthic Infestations Therapeutics (2012-2022)
        1.5.1 Asia-Pacific Helminthic Infestations Therapeutics Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Helminthic Infestations Therapeutics Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Helminthic Infestations Therapeutics Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Helminthic Infestations Therapeutics Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Helminthic Infestations Therapeutics Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Helminthic Infestations Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Helminthic Infestations Therapeutics (Volume and Value) by Type
        2.2.1 Asia-Pacific Helminthic Infestations Therapeutics Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Helminthic Infestations Therapeutics Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Helminthic Infestations Therapeutics (Volume) by Application
    2.4 Asia-Pacific Helminthic Infestations Therapeutics (Volume and Value) by Region
        2.4.1 Asia-Pacific Helminthic Infestations Therapeutics Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Helminthic Infestations Therapeutics Revenue and Market Share by Region (2012-2017)

3 China Helminthic Infestations Therapeutics (Volume, Value and Sales Price)
    3.1 China Helminthic Infestations Therapeutics Sales and Value (2012-2017)
        3.1.1 China Helminthic Infestations Therapeutics Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Helminthic Infestations Therapeutics Revenue and Growth Rate (2012-2017)
        3.1.3 China Helminthic Infestations Therapeutics Sales Price Trend (2012-2017)
    3.2 China Helminthic Infestations Therapeutics Sales Volume and Market Share by Type
    3.3 China Helminthic Infestations Therapeutics Sales Volume and Market Share by Application

4 Japan Helminthic Infestations Therapeutics (Volume, Value and Sales Price)
    4.1 Japan Helminthic Infestations Therapeutics Sales and Value (2012-2017)
        4.1.1 Japan Helminthic Infestations Therapeutics Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Helminthic Infestations Therapeutics Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Helminthic Infestations Therapeutics Sales Price Trend (2012-2017)
    4.2 Japan Helminthic Infestations Therapeutics Sales Volume and Market Share by Type
    4.3 Japan Helminthic Infestations Therapeutics Sales Volume and Market Share by Application

5 South Korea Helminthic Infestations Therapeutics (Volume, Value and Sales Price)
    5.1 South Korea Helminthic Infestations Therapeutics Sales and Value (2012-2017)
        5.1.1 South Korea Helminthic Infestations Therapeutics Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Helminthic Infestations Therapeutics Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Helminthic Infestations Therapeutics Sales Price Trend (2012-2017)
    5.2 South Korea Helminthic Infestations Therapeutics Sales Volume and Market Share by Type
    5.3 South Korea Helminthic Infestations Therapeutics Sales Volume and Market Share by Application

6 Taiwan Helminthic Infestations Therapeutics (Volume, Value and Sales Price)
    6.1 Taiwan Helminthic Infestations Therapeutics Sales and Value (2012-2017)
        6.1.1 Taiwan Helminthic Infestations Therapeutics Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Helminthic Infestations Therapeutics Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Helminthic Infestations Therapeutics Sales Price Trend (2012-2017)
    6.2 Taiwan Helminthic Infestations Therapeutics Sales Volume and Market Share by Type
    6.3 Taiwan Helminthic Infestations Therapeutics Sales Volume and Market Share by Application

7 India Helminthic Infestations Therapeutics (Volume, Value and Sales Price)
    7.1 India Helminthic Infestations Therapeutics Sales and Value (2012-2017)
        7.1.1 India Helminthic Infestations Therapeutics Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Helminthic Infestations Therapeutics Revenue and Growth Rate (2012-2017)
        7.1.3 India Helminthic Infestations Therapeutics Sales Price Trend (2012-2017)
    7.2 India Helminthic Infestations Therapeutics Sales Volume and Market Share by Type
    7.3 India Helminthic Infestations Therapeutics Sales Volume and Market Share by Application

8 Southeast Asia Helminthic Infestations Therapeutics (Volume, Value and Sales Price)
    8.1 Southeast Asia Helminthic Infestations Therapeutics Sales and Value (2012-2017)
        8.1.1 Southeast Asia Helminthic Infestations Therapeutics Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Helminthic Infestations Therapeutics Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Helminthic Infestations Therapeutics Sales Price Trend (2012-2017)
    8.2 Southeast Asia Helminthic Infestations Therapeutics Sales Volume and Market Share by Type
    8.3 Southeast Asia Helminthic Infestations Therapeutics Sales Volume and Market Share by Application

9 Australia Helminthic Infestations Therapeutics (Volume, Value and Sales Price)
    9.1 Australia Helminthic Infestations Therapeutics Sales and Value (2012-2017)
        9.1.1 Australia Helminthic Infestations Therapeutics Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Helminthic Infestations Therapeutics Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Helminthic Infestations Therapeutics Sales Price Trend (2012-2017)
    9.2 Australia Helminthic Infestations Therapeutics Sales Volume and Market Share by Type
    9.3 Australia Helminthic Infestations Therapeutics Sales Volume and Market Share by Application

10 Asia-Pacific Helminthic Infestations Therapeutics Players/Suppliers Profiles and Sales Data
    10.1 Neural Analytics, Inc.
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 M3 Biotechnology, Inc.
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Cerevance
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Cerevance Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Mitochon Pharmaceuticals, Inc.
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Peptilogics
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Peptilogics Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Farmoquimica S/A
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 biOasis Technologies, Inc.
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 HCA Healthcare, Inc.
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Alzeca Biosciences, Inc.
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Johnson & Johnson
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Helminthic Infestations Therapeutics Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview

11 Helminthic Infestations Therapeutics Manufacturing Cost Analysis
    11.1 Helminthic Infestations Therapeutics Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Helminthic Infestations Therapeutics

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Helminthic Infestations Therapeutics Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Helminthic Infestations Therapeutics Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Helminthic Infestations Therapeutics Market Forecast (2017-2022)
    15.1 Asia-Pacific Helminthic Infestations Therapeutics Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Helminthic Infestations Therapeutics Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Helminthic Infestations Therapeutics Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Helminthic Infestations Therapeutics Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Helminthic Infestations Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Helminthic Infestations Therapeutics Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Helminthic Infestations Therapeutics Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Helminthic Infestations Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Helminthic Infestations Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Helminthic Infestations Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Helminthic Infestations Therape